Berkeley Lights, Inc. (BLI) Stock
Berkeley Lights, Inc. (BLI) is a digital cell biology firm dedicated to empowering and expediting the advancement and market introduction of biotherapeutic and other cell-based products.
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Cash Flow (USD)
Valuation & Return Ratios
Peer Comparison
About Berkeley Lights, Inc.
Berkeley Lights, Inc. (BLI) is a digital cell biology firm dedicated to empowering and expediting the advancement and market introduction of biotherapeutic and other cell-based products. The company provides a unified technology platform, which encompasses proprietary consumables such as OptoSelect chips and specialized reagent kits, sophisticated automation systems, and purpose-built application and workflow software. BLI extends its services to clients across North America, the Asia Pacific region, and Europe. Founded in 2011, its corporate headquarters are located in Emeryville, California.
Berkeley Lights, Inc. is headquartered in US.
Berkeley Lights, Inc. (BLI) stock trades at $1.20 with a market capitalization of $86.61M. The stock is valued at a price-to-earnings (P/E) ratio of -0.85, price-to-book of 0.58, price-to-sales of 1.10. Over the past 52 weeks the stock has ranged between $0.98 and $7.40, and currently trades 83.8% below its 52-week high.
On profitability, Berkeley Lights, Inc. generates a return on equity (ROE) of -55.98%, return on capital employed of -52.35%, an operating margin of -120.29%, a net profit margin of -124.74%.
Official website: www.berkeleylights.com